Taken together, high level of NISCH expression was not a universal marker of good prognosis in cancer patients, not even within the same tumor group (such are adenocarcinomas BRCA, COAD, PAAD, LUAD, etc.), as it was previously postulated. This evidence concerns the gene NISCH and cancer.